Literature DB >> 33439308

Changes in plasma hydroxyproline and plasma cell-free DNA concentrations after higher- versus lower-intensity eccentric cycling.

Georgios Mavropalias1,2, Leslie Calapre3, Michael Morici3, Tomoko Koeda4, Wayne C K Poon3, Oliver R Barley3, Elin Gray3, Anthony J Blazevich3, Kazunori Nosaka3.   

Abstract

PURPOSE: We examined changes in plasma creatine kinase (CK) activity, hydroxyproline and cell-free DNA (cfDNA) concentrations in relation to changes in maximum voluntary isometric contraction (MVIC) torque and delayed-onset muscle soreness (DOMS) following a session of volume-matched higher- (HI) versus lower-intensity (LI) eccentric cycling exercise.
METHODS: Healthy young men performed either 5 × 1-min HI at 20% of peak power output (n = 11) or 5 × 4-min LI eccentric cycling at 5% of peak power output (n = 9). Changes in knee extensor MVIC torque, DOMS, plasma CK activity, and hydroxyproline and cfDNA concentrations before, immediately after, and 24-72 h post-exercise were compared between groups.
RESULTS: Plasma CK activity increased post-exercise (141 ± 73.5%) and MVIC torque decreased from immediately (13.3 ± 7.8%) to 48 h (6.7 ± 13.5%) post-exercise (P < 0.05), without significant differences between groups. DOMS was greater after HI (peak: 4.5 ± 3.0 on a 10-point scale) than LI (1.2 ± 1.0). Hydroxyproline concentration increased 40-53% at 24-72 h after both LI and HI (P < 0.05). cfDNA concentration increased immediately after HI only (2.3 ± 0.9-fold, P < 0.001), with a significant difference between groups (P = 0.002). Lack of detectable methylated HOXD4 indicated that the cfDNA was not derived from skeletal muscle. No significant correlations were evident between the magnitude of change in the measures, but the cfDNA increase immediately post-exercise was correlated with the maximal change in heart rate during exercise (r = 0.513, P = 0.025).
CONCLUSION: Changes in plasma hydroxyproline and cfDNA concentrations were not associated with muscle fiber damage, but the increased hydroxyproline in both groups suggests increased collagen turnover. cfDNA may be a useful metabolic-intensity exercise marker.

Entities:  

Keywords:  Connective tissue; Delayed onset muscle soreness; Eccentric exercise; Extracellular matrix; Maximal voluntary isometric contraction; Muscle damage

Year:  2021        PMID: 33439308     DOI: 10.1007/s00421-020-04593-1

Source DB:  PubMed          Journal:  Eur J Appl Physiol        ISSN: 1439-6319            Impact factor:   3.078


  41 in total

1.  Indices of skeletal muscle damage and connective tissue breakdown following eccentric muscle contractions.

Authors:  S J Brown; R B Child; S H Day; A E Donnelly
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1997

2.  Increased concentrations of cell-free plasma DNA after exhaustive exercise.

Authors:  Johanna Atamaniuk; Claudia Vidotto; Harald Tschan; Norbert Bachl; Karl M Stuhlmeier; Mathias M Müller
Journal:  Clin Chem       Date:  2004-09       Impact factor: 8.327

3.  Effects of ultra-marathon on circulating DNA and mRNA expression of pro- and anti-apoptotic genes in mononuclear cells.

Authors:  Johanna Atamaniuk; Karl M Stuhlmeier; Claudia Vidotto; Harald Tschan; Astrid Dossenbach-Glaninger; Mathias M Mueller
Journal:  Eur J Appl Physiol       Date:  2008-07-24       Impact factor: 3.078

4.  Cell-Free DNA as an Earlier Predictor of Exercise-Induced Performance Decrement Related to Muscle Damage.

Authors:  Michely V Andreatta; Victor M Curty; João Victor S Coutinho; Miguel Ângelo A Santos; Paula F Vassallo; Nuno F de Sousa; Valério G Barauna
Journal:  Int J Sports Physiol Perform       Date:  2018-07-28       Impact factor: 4.010

Review 5.  Neutrophil extracellular traps: a walk on the wild side of exercise immunology.

Authors:  Thomas Beiter; Annunziata Fragasso; Dominik Hartl; Andreas M Nieß
Journal:  Sports Med       Date:  2015-05       Impact factor: 11.136

6.  Neutrophils release extracellular DNA traps in response to exercise.

Authors:  Thomas Beiter; Annunziata Fragasso; Jens Hudemann; Marius Schild; Jürgen Steinacker; Frank C Mooren; Andreas M Niess
Journal:  J Appl Physiol (1985)       Date:  2014-05-15

7.  Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise.

Authors:  Sarah Breitbach; Björn Sterzing; Carlos Magallanes; Suzan Tug; Perikles Simon
Journal:  J Appl Physiol (1985)       Date:  2014-05-29

8.  Cell-free plasma DNA and purine nucleotide degradation markers following weightlifting exercise.

Authors:  Johanna Atamaniuk; Claudia Vidotto; Markus Kinzlbauer; Norbert Bachl; Beate Tiran; Harald Tschan
Journal:  Eur J Appl Physiol       Date:  2010-06-26       Impact factor: 3.078

9.  Short-term treadmill running as a model for studying cell-free DNA kinetics in vivo.

Authors:  Thomas Beiter; Annunziata Fragasso; Jens Hudemann; Andreas M Niess; Perikles Simon
Journal:  Clin Chem       Date:  2011-02-04       Impact factor: 8.327

Review 10.  Circulating cell-free DNA: an up-coming molecular marker in exercise physiology.

Authors:  Sarah Breitbach; Suzan Tug; Perikles Simon
Journal:  Sports Med       Date:  2012-07-01       Impact factor: 11.928

View more
  3 in total

1.  Increases in Integrin-ILK-RICTOR-Akt Proteins, Muscle Mass, and Strength after Eccentric Cycling Training.

Authors:  Georgios Mavropalias; Yu-Fu Wu; Marni D Boppart; Anthony J Blazevich; Kazunori Nosaka
Journal:  Med Sci Sports Exerc       Date:  2022-01-01       Impact factor: 5.411

Review 2.  The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma.

Authors:  Nicole Laurencia Yuwono; Kristina Warton; Caroline Elizabeth Ford
Journal:  Elife       Date:  2021-11-09       Impact factor: 8.140

Review 3.  Exercise medicine for cancer cachexia: targeted exercise to counteract mechanisms and treatment side effects.

Authors:  Georgios Mavropalias; Marc Sim; Dennis R Taaffe; Daniel A Galvão; Nigel Spry; William J Kraemer; Keijo Häkkinen; Robert U Newton
Journal:  J Cancer Res Clin Oncol       Date:  2022-01-27       Impact factor: 4.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.